{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:55:43Z","timestamp":1781650543734,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary tuberculosis (PTB) remains a major cause of morbidity and mortality globally. Gram-positive cocci (GPC) among tuberculosis patients may complicate clinical outcomes and contribute to antimicrobial resistance. Methicillin resistance and inducible clindamycin resistance mediated by macrolide-lincosamide-streptogramin B (MLSB) phenotypes pose significant therapeutic challenges by limiting effective treatment options and contributing to treatment failure. In Ethiopia, data on methicillin resistance and inducible clindamycin resistance in Gram-positive cocci among PTB patients and apparently healthy individuals are scarce. This study aimed to determine the prevalence, methicillin and inducible clindamycin resistance and associated factors of Gram-positive cocci among PTB patients and apparently healthy individuals in Northwest Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was conducted among 300 participants, comprising 150 GeneXpert-positive PTB patients and 150 apparently healthy individuals, recruited from comprehensive specialized hospitals and the community, respectively. Sputum specimens were collected aseptically and cultured on blood and chocolate agar plates. Isolates were identified using standard microbiological methods and subjected to antimicrobial susceptibility tests by the disk diffusion method. Moreover, the D-test was performed to detect inducible clindamycin resistance. Data was analyzed using SPSS version 28. Binary logistic regression was used for the analysis, and\n                      <jats:italic>p<\/jats:italic>\n                      -values\u2009\n                      <jats:italic>\u2264<\/jats:italic>\n                      \u20090.05 with 95% CI were considered statistically significant. Antimicrobial susceptibility tests were analyzed using WHONET-2024 software.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the current study, the overall prevalence of Gram-positive cocci was 32.0% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200996). The prevalence was significantly higher among PTB patients (60\/150; 40.0%) compared with apparently healthy individuals (36\/150; 24.0%).\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      was the most common isolate (31.3%), followed by\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      (29.2%) and coagulase-negative staphylococci (CONS) (16.7%) in both groups. Multidrug resistance (MDR) was observed in (84.2% and 81.8%) of\n                      <jats:italic>S. aureus<\/jats:italic>\n                      and 100% of CONS from PTB patients and apparently healthy individuals equally. Inducible clindamycin resistance (iMLSB) was detected among\n                      <jats:italic>S. aureus<\/jats:italic>\n                      (31.6% and 18.2%) and CONS (10.0% and 16.7%) in PTB patients and apparently healthy individuals, respectively. Overall methicillin resistance among GPC was 60.3%, with rates of 64.3% in PTB patients and 53.8% among apparently healthy individuals. A correlation analysis demonstrated a strong positive association between rifampicin-resistant\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      and methicillin-resistant\n                      <jats:italic>S. aureus<\/jats:italic>\n                      (MRSA) (\u03c6\u2009=\u20090.685). In multivariate analysis, age and educational status were independently associated with Gram-positive cocci (GPC) positivity among PTB patients. Patients aged\u2009\u2265\u200966 years had lower odds of GPC positivity (AOR: 0.27; 95% CI: 0.07\u20130.98), whereas participants with grades 5\u20138 education had higher odds (AOR: 8.65; 95% CI: 1.55\u201334.40). Cigarette smoking was inversely associated with GPC isolation (AOR: 0.43; 95% CI: 0.18\u20130.97). Among apparently healthy individuals, grades 5\u20138 education was more likely to harbor GPC (AOR: 7.75; 95% CI: 1.26\u201324.57).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates a high burden of Gram-positive cocci colonization among PTB patients, frequent MDR and methicillin resistance, and inducible clindamycin resistance. The strong association between rifampicin-resistant Mtb among PTB patients and MRSA highlights the clinical relevance of coexisting drug resistance. The substantial burden of antimicrobial resistance underscores the need for routine D-tests, bacterial surveillance, and targeted infection control, especially among high-risk groups such as PTB patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-026-05071-y","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T13:24:22Z","timestamp":1776518662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methicillin and inducible clindamycin resistance in Gram-positive cocci among GeneXpert-positive pulmonary tuberculosis patients and apparently healthy individuals in Northwest Ethiopia"],"prefix":"10.1186","volume":"26","author":[{"given":"Tebelay","family":"Dilnessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feleke","family":"Moges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belay","family":"Tessema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Workagegnehu","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baye","family":"Gelaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"5071_CR1","unstructured":"WHO. WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis-Rapid diagnostics for tuberculosis detection. Geneva: World Health Organization. 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK602012\/?utm_source=chatgpt.com."},{"key":"5071_CR2","unstructured":"WHO. Global tuberculosis report 2023. Geneva: World Health Organization. 2023. License: CC BY-NC-SA 3.0 IGO. Available from: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2023\/."},{"issue":"8","key":"5071_CR3","first-page":"e66482","volume":"16","author":"R Bir","year":"2024","unstructured":"Bir R, Ranjan R, Gunasekaran J, Chatterjee K, Karteeka D, Rai A, et al. Prevalence of Co-infection of Culture-Proven Bacterial Pathogens in Microbiologically Confirmed Pulmonary Tuberculosis Patients From a Tertiary Care Center. Cureus. 2024;16(8):e66482.","journal-title":"Cureus"},{"issue":"7","key":"5071_CR4","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/jcm14072154","volume":"14","author":"R Cioboata","year":"2025","unstructured":"Cioboata R, Balteanu MA, Osman A, Vlasceanu SG, Zlatian OM, Mitroi DM, et al. Coinfections in Tuberculosis in Low- and Middle-Income Countries: Epidemiology, Clinical Implications, Diagnostic Challenges, and Management Strategies- A Narrative Review. J Clin Med. 2025;14(7):2154.","journal-title":"J Clin Med"},{"key":"5071_CR5","doi-asserted-by":"publisher","first-page":"749905","DOI":"10.3389\/fcimb.2021.749905","volume":"11","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Song J, Yang C, Yang L, Chen J, Li X, et al. Prevalence of Fungal and Bacterial Co-Infection in Pulmonary Fungal Infections: A Metagenomic Next Generation Sequencing-Based Study. Front Cell Infect Microbiol. 2021;11:749905.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"5071_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/jrms.jrms_446_23","volume":"30","author":"Y Wu","year":"2025","unstructured":"Wu Y, Wang C, Li Y. Status and outlook of pulmonary tuberculosis coinfection. J Res Med Sci. 2025;30(1):34.","journal-title":"J Res Med Sci"},{"key":"5071_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/IDR.S397513","volume":"16","author":"W Mai","year":"2023","unstructured":"Mai W, Liu Y, Meng Q, Xu J, Wu J. Bacterial Epidemiology and Antimicrobial Resistance Profiles of Respiratory Specimens of Children with Pneumonia in Hainan, China. Infect Drug Resist. 2023;16:249\u201361.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"5071_CR8","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1128\/JCM.42.4.1800-1802.2004","volume":"42","author":"JH Jorgensen","year":"2004","unstructured":"Jorgensen JH, Crawford SA, McElmeel ML, Fiebelkorn KR. Detection of Inducible Clindamycin Resistance of Staphylococci in Conjunction with Performance of Automated Broth Susceptibility Testing. J Clin Microbiol. 2004;42(4):1800\u20132.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"5071_CR9","first-page":"82","volume":"4","author":"N Seifi","year":"2012","unstructured":"Seifi N, Kahani N, Askari E, Mahdipour S, Naderi NM. Inducible clindamycin resistance in Staphylococcus aureus isolates recovered from Mashhad, Iran. Iran J Microbiol. 2012;4(2):82\u20136.","journal-title":"Iran J Microbiol"},{"issue":"3","key":"5071_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1568005043340777","volume":"4","author":"G Maravi\u0107","year":"2004","unstructured":"Maravi\u0107 G. Macrolide resistance based on the Erm-mediated rRNA methylation. Curr Drug Targets Infect Disord. 2004;4(3):193\u2013202.","journal-title":"Curr Drug Targets Infect Disord"},{"key":"5071_CR11","doi-asserted-by":"crossref","unstructured":"Fyfe C, Grossman TH, Kerstein K, Sutcliffe J. Resistance to macrolide antibiotics in public health pathogens. Cold Spring Harb Perspect Med. 2016;6(10):a0255395.","DOI":"10.1101\/cshperspect.a025395"},{"issue":"1","key":"5071_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12916-025-04097-9","volume":"23","author":"SA Abdel-Karim","year":"2025","unstructured":"Abdel-Karim SA, Serry FM, Elmasry EM, Hegazy WAH. Phenotypic and genotypic characteristics of macrolide, lacosamide, and streptogramin resistance in clinically resistant Streptococci and their correlation with reduced biocide susceptibility. BMC Med. 2025;23(1):281.","journal-title":"BMC Med"},{"key":"5071_CR13","doi-asserted-by":"publisher","first-page":"6503929","DOI":"10.1155\/2022\/6503929","volume":"2022","author":"A Ambachew","year":"2022","unstructured":"Ambachew A, Gebrecherkos T, Ayalew G. Prevalence and Clindamycin Resistance Profile of Staphylococcus aureus and Associated Factors among Patients Attending the University of Gondar Comprehensive Specialized Hospital, Gondar, Northwest Ethiopia. Interdiscip Perspect Infect Dis. 2022;2022:6503929.","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"5071_CR14","doi-asserted-by":"publisher","first-page":"3848073","DOI":"10.1155\/2023\/3848073","volume":"2023","author":"F Moges","year":"2023","unstructured":"Moges F, Tamiru T, Amare A, Mengistu G, Eshetie S, Dagnew M, et al. Prevalence of Methicillin-Resistant Staphylococcus aureus and Multidrug-Resistant Strains from Patients Attending the Referral Hospitals of Amhara Regional State, Ethiopia. Int J Microbiol. 2023;2023:3848073.","journal-title":"Int J Microbiol"},{"issue":"2","key":"5071_CR15","doi-asserted-by":"publisher","first-page":"e0319295","DOI":"10.1371\/journal.pone.0319295","volume":"20","author":"H Eshete","year":"2025","unstructured":"Eshete H, Tileku M, Aschenaki A, Shiferaw E, Mulugeta H, Teferi M, et al. Ethiopian antimicrobial consumption trends in human health sector: A surveillance report 2020\u20132022. PLoS ONE. 2025;20(2):e0319295.","journal-title":"PLoS ONE"},{"key":"5071_CR16","doi-asserted-by":"publisher","first-page":"100527","DOI":"10.1016\/j.onehlt.2023.100527","volume":"16","author":"AM Beyene","year":"2023","unstructured":"Beyene AM, Andualem T, Dagnaw GG, Getahun M, LeJeune J, Ferreira JP. Situational analysis of antimicrobial resistance, laboratory capacities, surveillance systems and containment activities in Ethiopia: A new and one health approach. One Health. 2023;16:100527.","journal-title":"One Health"},{"issue":"2","key":"5071_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.4102\/ajlm.v7i2.770","volume":"7","author":"RA Ibrahim","year":"2018","unstructured":"Ibrahim RA, Teshal AM, Dinku SF, Abera NA, Negeri AA, Desta FG, et al. Antimicrobial resistance surveillance in Ethiopia: Implementation experiences and lessons learned. Afr J Lab Med. 2018;7(2):770.","journal-title":"Afr J Lab Med"},{"key":"5071_CR18","unstructured":"WHO. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization. 2018. License: CC BY-NC-SA 3.0. Available from: https:\/\/iris.who.int\/handle\/10665\/260233\/."},{"key":"5071_CR19","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute. 2024. Available from: https:\/\/clsi.org\/shop\/standards\/m100\/."},{"key":"5071_CR20","unstructured":"WHONET. WHONET software for the surveillance of antimicrobial resistance. Version 2024. Boston, USA: WHO Collaborating Centre for Surveillance of Antimicrobial Resistance, Brigham and Women\u2019s Hospital. 2024. Available from: https:\/\/www.whonet.org."},{"issue":"3","key":"5071_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"5071_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/324626","volume":"34","author":"R Leclercq","year":"2002","unstructured":"Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34(4):482\u201392.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5071_CR23","first-page":"131","volume":"55","author":"V Ungureanu","year":"2010","unstructured":"Ungureanu V. Macrolides, lincosamides, streptogramines (MLS): mechanisms of action and resistance. Bacteriol Virusol Parazitol Epidemiol. 2010;55(2):131\u20138.","journal-title":"Bacteriol Virusol Parazitol Epidemiol"},{"key":"5071_CR24","unstructured":"WHO. National guidelines for TB, drug resistant TB And leprosy in Ethiopia. Sixth Ed. 2017. Available from: https:\/\/www.afro.who.int\/publications\/national-guidelines-tb-drug-resistant-tb-and-leprosy-ethiopia-sixth-edition\/."},{"issue":"3","key":"5071_CR25","first-page":"96","volume":"5","author":"KD Verma","year":"2015","unstructured":"Verma KD, Barasa A, Dara D, W\/Medehen H, Asrat H, Demissie N, et al. Isolation and characterization of bacteria from mobile phones of students and employees at University of Gondar, Ethiopia. Bull Pharm Res. 2015;5(3):96\u2013100.","journal-title":"Bull Pharm Res"},{"issue":"10","key":"5071_CR26","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1086\/587658","volume":"46","author":"P Katona","year":"2008","unstructured":"Katona P, Katona-Apte J. The Interaction between Nutrition and Infection. Clin Infect Dis. 2008;46(10):1582\u20138.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"5071_CR27","doi-asserted-by":"publisher","first-page":"e01391","DOI":"10.1128\/JCM.01391-19","volume":"57","author":"CP Morris","year":"2019","unstructured":"Morris CP, Simner PJJ. Tailoring antimicrobial susceptibility testing to individual species of coagulase-negative staphylococci: next up, Staphylococcus epidermidis. J Clin Microbiol. 2019;57(12):e01391\u201319.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5071_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-6-125","volume":"6","author":"AO Shittu","year":"2006","unstructured":"Shittu AO, Lin JJ. Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South Africa. BMC Infect Dis. 2006;6(1):1\u201313.","journal-title":"BMC Infect Dis"},{"key":"5071_CR29","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.2147\/IDR.S372930","volume":"15","author":"NM Gebremariam","year":"2022","unstructured":"Gebremariam NM, Bitew A, Tsige E, Woldesenbet D, Tola MA. A High Level of Antimicrobial Resistance in Gram-Positive Cocci Isolates from Different Clinical Samples Among Patients Referred to Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia. Infect Drug Resist. 2022;15:4203\u201312.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5071_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13756-021-00965-0","volume":"10","author":"DF Berhe","year":"2021","unstructured":"Berhe DF, Beyene GT, Seyoum B, Gebre M, Haile K, Tsegaye M, et al. Prevalence of antimicrobial resistance and its clinical implications in Ethiopia: a systematic review. Antimicrob Resist Infect Control. 2021;10(1):168.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"5071_CR31","doi-asserted-by":"publisher","first-page":"30047","DOI":"10.1038\/s41598-025-15472-0","volume":"15","author":"G Alemayehu","year":"2025","unstructured":"Alemayehu G, Geteneh A, Dessale M, Ayalew E, Demeke G, Reta A, et al. High prevalence of penicillin-resistant group B Streptococcus among pregnant women in Northwest Ethiopia. Sci Rep. 2025;15(1):30047.","journal-title":"Sci Rep"},{"key":"5071_CR32","doi-asserted-by":"publisher","first-page":"101229","DOI":"10.1016\/j.onehlt.2025.101229","volume":"21","author":"MD Fenta","year":"2025","unstructured":"Fenta MD, Bitew AB, Demisse BW, Abey SL, Mengistu BA, Kinde MZ, et al. Systematic review and meta-analysis of Staphylococcus aureus at the human-animal-environment Interface in eastern Africa: Prevalence, virulence genes, and antimicrobial resistance profile. One Health. 2025;21:101229.","journal-title":"One Health"},{"key":"5071_CR33","doi-asserted-by":"crossref","unstructured":"Touaitia R, Mairi A, Ibrahim NA, Basher NS, Idres T, Touati A. Staphylococcus aureus: a review of the pathogenesis and virulence mechanisms. Antibiotics (Basel). 2025;14(5):1\u201337.","DOI":"10.3390\/antibiotics14050470"},{"issue":"1","key":"5071_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s13104-020-05369-8","volume":"13","author":"RS Regmi","year":"2020","unstructured":"Regmi RS, Khadka S, Sapkota S, Adhikari S, Dhakal KK, Dhakal B, et al. Bacterial etiology of sputum from tuberculosis suspected patients and antibiogram of the isolates. BMC Res Notes. 2020;13(1):520.","journal-title":"BMC Res Notes"},{"key":"5071_CR35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1471-2180-12-276","volume":"12","author":"Z Cui","year":"2012","unstructured":"Cui Z, Zhou Y, Li H, Zhang Y, Zhang S, Tang S, et al. Complex sputum microbial composition in patients with pulmonary tuberculosis. BMC Microbiol. 2012;12:276.","journal-title":"BMC Microbiol"},{"issue":"4","key":"5071_CR36","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/microorganisms10040703","volume":"10","author":"FS Buchera","year":"2022","unstructured":"Buchera FS, Silago V, Japhet G, Mtemisika CI, Damiano P, Nyawale HA, et al. Predominance of Other Pathogenic Bacteria among Presumptive Tuberculosis Cases Attending Tuberculosis Clinics in Mwanza, Tanzania: A Cross-Sectional Laboratory-Based Study. Microorganisms. 2022;10(4):703.","journal-title":"Microorganisms"},{"issue":"24","key":"5071_CR37","first-page":"12","volume":"5","author":"JB Owolabi","year":"2015","unstructured":"Owolabi JB, Olorioke RC. Prevalence and antimicrobial susceptibility of methicillin resistant Staphylococcus aureus and coagulase-negative staphylococci isolated from apparently healthy university students in Ota, Nigeria. J Nat Sci Res. 2015;5(24):12\u20138.","journal-title":"J Nat Sci Res"},{"key":"5071_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jgar.2021.10.025","volume":"29","author":"L Chelkeba","year":"2022","unstructured":"Chelkeba L, Melaku T. Epidemiology of Staphylococci species and their antimicrobial-resistance among patients with wound infection in Ethiopia: a systematic review and meta-analysis. J Glob Antimicrob Resist. 2022;29:483\u201398.","journal-title":"J Glob Antimicrob Resist"},{"key":"5071_CR39","doi-asserted-by":"publisher","first-page":"100390","DOI":"10.1016\/j.onehlt.2022.100390","volume":"14","author":"M Tweldemedhin","year":"2022","unstructured":"Tweldemedhin M, Muthupandian S, Gebremeskel TK, Mehari K, Abay GK, Teklu TG, et al. Multidrug resistance from a one health perspective in Ethiopia: A systematic review and meta-analysis of literature (2015\u20132020). One Health. 2022;14:100390.","journal-title":"One Health"},{"issue":"1","key":"5071_CR40","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1186\/s12879-025-11427-y","volume":"25","author":"B Sharew","year":"2025","unstructured":"Sharew B, Tilahun M. Bacterial profile and antimicrobial resistance patterns among pediatrics patients with suspected bloodstream infections in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2025;25(1):1008.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"5071_CR41","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18\u201355.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"5071_CR42","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S0163-4453(09)60003-7","volume":"59","author":"N Woodford","year":"2009","unstructured":"Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect. 2009;59(Suppl 1):S4\u201316.","journal-title":"J Infect"},{"key":"5071_CR43","doi-asserted-by":"crossref","unstructured":"Navidifar T, Zare Banadkouki A, Parvizi E, Mofid M, Golab N, Beig M, et al. Global prevalence of macrolide-resistant Staphylococcus spp.: a comprehensive systematic review and meta-analysis. Front Microbiol. 2025;16:1524452.","DOI":"10.3389\/fmicb.2025.1524452"},{"key":"5071_CR44","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.2147\/IDR.S429687","volume":"16","author":"A Abdeta","year":"2023","unstructured":"Abdeta A, Beyene D, Negeri AA. Antimicrobial Resistance Patterns of Staphylococcus aureus and Enterococcus Species at the Ethiopian Public Health Institute, Ethiopia: A Five-Year Retrospective Analysis. Infect Drug Resist. 2023;16:6155\u201366.","journal-title":"Infect Drug Resist"},{"key":"5071_CR45","doi-asserted-by":"publisher","first-page":"1835603","DOI":"10.1155\/2022\/1835603","volume":"2022","author":"M Assefa","year":"2022","unstructured":"Assefa M. Inducible Clindamycin-Resistant Staphylococcus aureus Strains in Africa: A Systematic Review. Int J Microbiol. 2022;2022:1835603.","journal-title":"Int J Microbiol"},{"issue":"7","key":"5071_CR46","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3855\/jidc.6336","volume":"9","author":"A Banik","year":"2015","unstructured":"Banik A, Khyriem AB, Gurung J, Lyngdoh VW. Inducible and constitutive clindamycin resistance in Staphylococcus aureus in a northeastern Indian tertiary care hospital. J Infect Dev Ctries. 2015;9(7):725\u201331.","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"5071_CR47","first-page":"1","volume":"77","author":"L Nahar","year":"2023","unstructured":"Nahar L, Hagiya H, Nada T, Iio K, Gotoh K, Matsushita O, et al. Prevalence of Inducible Macrolide, Lincosamide, and Streptogramin B (inducible MLSB) Resistance in Clindamycin-Susceptible Staphylococcus aureus at Okayama University Hospital. Acta Med Okayama. 2023;77(1):1\u20139.","journal-title":"Acta Med Okayama"},{"issue":"2","key":"5071_CR48","doi-asserted-by":"publisher","first-page":"Br48","DOI":"10.12659\/MSM.881386","volume":"17","author":"H Saderi","year":"2011","unstructured":"Saderi H, Emadi B, Owlia P. Phenotypic and genotypic study of macrolide, lincosamide and streptogramin B (MLSB) resistance in clinical isolates of Staphylococcus aureus in Tehran, Iran. Med Sci Monit. 2011;17(2):Br48\u201353.","journal-title":"Med Sci Monit"},{"issue":"4","key":"5071_CR49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ijantimicag.2007.11.014","volume":"31","author":"ES Cetin","year":"2008","unstructured":"Cetin ES, Gunes H, Kaya S, Aridogan BC, Demirci M. Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates. Int J Antimicrob Agents. 2008;31(4):364\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"5071_CR50","doi-asserted-by":"crossref","unstructured":"Addis Z, Aschale Y, Fenta A, Teffera ZH, Melkamu A, Tigab A, et al. Methicillin and inducible clindamycin resistance in clinical Staphylococcus aureus isolates: a cross-sectional study from Northwest Ethiopia. Front Microbiol. 2025;16:1569242.","DOI":"10.3389\/fmicb.2025.1569242"},{"issue":"1","key":"5071_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0924-8579(02)00253-4","volume":"21","author":"E Petinaki","year":"2003","unstructured":"Petinaki E, Kontos F, Pratti A, Skulakis C, Maniatis AN. Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece. Int J Antimicrob Agents. 2003;21(1):67\u201370.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"5071_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1469-0691.2005.01101.x","volume":"11","author":"S Fokas","year":"2005","unstructured":"Fokas S, Fokas S, Tsironi M, Kalkani M, Dionysopouloy M. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin Microbiol Infect. 2005;11(4):337\u201340.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5071_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1128\/AAC.45.1.339-341.2001","volume":"45","author":"EL Palavecino","year":"2001","unstructured":"Palavecino EL, Riedel I, Berrios X, Bajaksouzian S, Johnson D, Kaplan E, et al. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob Agents Chemother. 2001;45(1):339\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"5071_CR54","doi-asserted-by":"publisher","first-page":"105258","DOI":"10.1016\/j.meegid.2022.105258","volume":"99","author":"R Rafei","year":"2022","unstructured":"Rafei R, Al Iaali R, Osman M, Dabboussi F, Hamze M. A global snapshot on the prevalent macrolide-resistant emm types of Group A Streptococcus worldwide, their phenotypes and their resistance marker genotypes during the last two decades: A systematic review. Infect Genet Evol. 2022;99:105258.","journal-title":"Infect Genet Evol"},{"issue":"7","key":"5071_CR55","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.18203\/2320-6012.ijrms20172999","volume":"5","author":"J Shetty","year":"2017","unstructured":"Shetty J, Afroz Z. Prevalence of constitutive and inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care institute in North India. Int J Res Med Sci. 2017;5(7):3120\u20135.","journal-title":"Int J Res Med Sci"},{"issue":"3","key":"5071_CR56","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0255-0857(21)01877-6","volume":"26","author":"MR Angel","year":"2008","unstructured":"Angel MR, Balaji V, Prakash J, Brahmadathan KN, Mathews MS. Prevalence of inducible clindamycin resistance in Gram-positive organisms in a tertiary care centre. Indian J Med Microbiol. 2008;26(3):262\u20134.","journal-title":"Indian J Med Microbiol"},{"key":"5071_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13756-017-0243-7","volume":"6","author":"S Deyno","year":"2017","unstructured":"Deyno S, Fekadu S, Astatkie A. Resistance of Staphylococcus aureus to antimicrobial agents in Ethiopia: a meta-analysis. Antimicrob Resist Infect Control. 2017;6:85.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5071_CR58","doi-asserted-by":"crossref","unstructured":"Dilnessa T, Bitew A. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia. BMC Infect Dis. 2016;16(398):1\u20139.","DOI":"10.1186\/s12879-016-1742-5"},{"issue":"1","key":"5071_CR59","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1186\/s12879-025-11842-1","volume":"25","author":"I Tsige","year":"2025","unstructured":"Tsige I, Reda DY, Kefeni M, Merid Y, Negash AA, Kwatra G, et al. Prevalence and associated factors of methicillin-resistant and vancomycin-susceptible Staphylococcus aureus among clinical isolates at Hawassa university comprehensive specialized hospital, Ethiopia, 2019\u20132023. BMC Infect Dis. 2025;25(1):1388.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"5071_CR60","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/jac\/dki364","volume":"56","author":"Y Liu","year":"2005","unstructured":"Liu Y, Cui J, Wang R, Wang X, Drlica K, Zhao X. Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance. J Antimicrob Chemother. 2005;56(6):1172\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"5071_CR61","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ijantimicag.2011.01.018","volume":"37","author":"CK Tan","year":"2011","unstructured":"Tan CK, Lai CC, Liao CH, Lin SH, Huang YT, Hsueh PR. Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment. Int J Antimicrob Agents. 2011;37(6):550\u20133.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"5071_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10156-005-0417-8","volume":"12","author":"J Sekiguchi","year":"2006","unstructured":"Sekiguchi J, Fujino T, Araake M, Toyota E, Kudo K, Saruta K, et al. Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards. J Infect Chemother. 2006;12(1):47\u201350.","journal-title":"J Infect Chemother"},{"issue":"8","key":"5071_CR63","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/resp.12851","volume":"21","author":"JM Sahuquillo-Arce","year":"2016","unstructured":"Sahuquillo-Arce JM, Men\u00e9ndez R, M\u00e9ndez R, Amara-Elori I, Zalacain R, Capelastegui A, et al. Age-related risk factors for bacterial aetiology in community-acquired pneumonia. Respirol (Carlton Vic). 2016;21(8):1472\u20139.","journal-title":"Respirol (Carlton Vic)"},{"key":"5071_CR64","doi-asserted-by":"crossref","unstructured":"Yacouba A, Zeidou Alassoum M, Marou Soumana B, Moussa Saley S, Ousmane A, Moussa H, et al. Inducible clindamycin resistance among clinical gram-positive cocci in a tertiary hospital in Niger Republic. Access Microbiol. 2024;6(10):000708.v4.","DOI":"10.1099\/acmi.0.000708.v4"},{"issue":"1","key":"5071_CR65","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12879-025-10633-y","volume":"25","author":"O Yimer","year":"2025","unstructured":"Yimer O, Abebaw A, Adugna A, Adane F, Esmael A. Bacterial profile, antimicrobial susceptibility patterns, and associated factors among lower respiratory tract infection patients attending at Debre Markos comprehensive specialized hospital, Northwest, Ethiopia. BMC Infect Dis. 2025;25(1):266.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"5071_CR66","doi-asserted-by":"publisher","first-page":"e0262956","DOI":"10.1371\/journal.pone.0262956","volume":"17","author":"M Assefa","year":"2022","unstructured":"Assefa M, Tigabu A, Belachew T, Tessema B. Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study. PLoS ONE. 2022;17(2):e0262956.","journal-title":"PLoS ONE"},{"issue":"1","key":"5071_CR67","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1186\/s12879-025-10819-4","volume":"25","author":"A Azzam","year":"2025","unstructured":"Azzam A, Khaled H, Fayed HM, Mansour Y, Eldalil M, Elshennawy E, et al. Prevalence, antibiogram, and risk factors of methicillin-resistant Staphylococcus aureus (MRSA) asymptomatic carriage in Africa: a systematic review and meta-analysis. BMC Infect Dis. 2025;25(1):505.","journal-title":"BMC Infect Dis"},{"issue":"3 Pt 1","key":"5071_CR68","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0761-8425(04)71358-3","volume":"21","author":"V Trosini-Desert","year":"2004","unstructured":"Trosini-Desert V, Germaud P, Dautzenberg B. Tobacco smoke and risk of bacterial infection. Rev Mal Respir. 2004;21(3 Pt 1):539\u201347.","journal-title":"Rev Mal Respir"},{"issue":"7","key":"5071_CR69","doi-asserted-by":"publisher","first-page":"e0220204","DOI":"10.1371\/journal.pone.0220204","volume":"14","author":"V Baskaran","year":"2019","unstructured":"Baskaran V, Murray RL, Hunter A, Lim WS, McKeever TM. Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysis. PLoS ONE. 2019;14(7):e0220204.","journal-title":"PLoS ONE"},{"issue":"1","key":"5071_CR70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1617-9625-4-12","volume":"4","author":"J Bagaitkar","year":"2008","unstructured":"Bagaitkar J, Demuth DR, Scott DA. Tobacco use increases susceptibility to bacterial infection. Tob Induc Dis. 2008;4(1):12.","journal-title":"Tob Induc Dis"},{"issue":"4","key":"5071_CR71","doi-asserted-by":"publisher","first-page":"e0000327","DOI":"10.1371\/journal.pgph.0000327","volume":"2","author":"EFG Neal","year":"2022","unstructured":"Neal EFG, Chan J, Nguyen CD, Russell FM. Factors associated with pneumococcal nasopharyngeal carriage: A systematic review. PLOS Glob Public Health. 2022;2(4):e0000327.","journal-title":"PLOS Glob Public Health"},{"key":"5071_CR72","doi-asserted-by":"crossref","unstructured":"Parker AM, Jackson N, Awasthi S, Kim H, Alwan T, Wyllie AL, et al. Upper respiratory Streptococcus pneumoniae colonization among working-age adults with prevalent exposure to overcrowding. Microbiol Spectr. 2024;12(8):e0087924.","DOI":"10.1128\/spectrum.00879-24"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05071-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05071-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05071-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:21:40Z","timestamp":1781648500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05071-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5071"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05071-y","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical clearance was obtained from the Institutional Review Board (IRB) of the College of Medicine and Health Sciences of the University of Gondar (Ref. number: CMHS\/SH\/RTT\/CoMEng\/06\/216\/3\/2015). Written permission letter was obtained from Debre Markos, Felege-Hiwot, and the University of Gondar Comprehensive Specialized Hospitals for the data collection process. Written informed assent and consent was obtained from the parents\/guardians and study participants, respectively. Participation was based on voluntarism. The confidentiality and anonymity of all participants information were strictly maintained throughout the research process. Participants were provided with appropriate counseling and referral services whenever necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"517"}}